REPORT ID 10206

Global Anti-epileptic Drugs for Pediatrics Market Research Report 2017

Publish Date
16-Nov-17
Pages
110
Format
Electronic (PDF)

In this report, the global Anti-epileptic Drugs for Pediatrics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Anti-epileptic Drugs for Pediatrics in these regions, from 2012 to 2022 (forecast), covering
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
Global Anti-epileptic Drugs for Pediatrics market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    Mylan N.V.
    Cephalon, Inc.
    GlaxoSmithKline plc
    Janssen Pharmaceuticals
    Novartis AG
    Pfizer, Inc.
    Sanofi S.A.
    UCB Pharma Limited
    Sunovion Pharmaceuticals Limited
    Valeant Pharmaceuticals International, Inc.
    Zogenix
    GW Pharmaceuticals
    Insys
    Zynerba
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    First Generation
    Second Generation
    Third Generation
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
    Clinic
    Hospital
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Anti-epileptic Drugs for Pediatrics Market Research Report 2017
1 Anti-epileptic Drugs for Pediatrics Market Overview
    1.1 Product Overview and Scope of Anti-epileptic Drugs for Pediatrics
    1.2 Anti-epileptic Drugs for Pediatrics Segment by Type (Product Category)
        1.2.1 Global Anti-epileptic Drugs for Pediatrics Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
        1.2.2 Global Anti-epileptic Drugs for Pediatrics Production Market Share by Type (Product Category) in 2016
        1.2.3 First Generation
        1.2.4 Second Generation
        1.2.5 Third Generation
    1.3 Global Anti-epileptic Drugs for Pediatrics Segment by Application
        1.3.1 Anti-epileptic Drugs for Pediatrics Consumption (Sales) Comparison by Application (2012-2022)
        1.3.2 Clinic
        1.3.3 Hospital
        1.3.4 Others
    1.4 Global Anti-epileptic Drugs for Pediatrics Market by Region (2012-2022)
        1.4.1 Global Anti-epileptic Drugs for Pediatrics Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
        1.4.2 North America Status and Prospect (2012-2022)
        1.4.3 Europe Status and Prospect (2012-2022)
        1.4.4 China Status and Prospect (2012-2022)
        1.4.5 Japan Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Status and Prospect (2012-2022)
        1.4.7 India Status and Prospect (2012-2022)
    1.5 Global Market Size (Value) of Anti-epileptic Drugs for Pediatrics (2012-2022)
        1.5.1 Global Anti-epileptic Drugs for Pediatrics Revenue Status and Outlook (2012-2022)
        1.5.2 Global Anti-epileptic Drugs for Pediatrics Capacity, Production Status and Outlook (2012-2022)

2 Global Anti-epileptic Drugs for Pediatrics Market Competition by Manufacturers
    2.1 Global Anti-epileptic Drugs for Pediatrics Capacity, Production and Share by Manufacturers (2012-2017)
        2.1.1 Global Anti-epileptic Drugs for Pediatrics Capacity and Share by Manufacturers (2012-2017)
        2.1.2 Global Anti-epileptic Drugs for Pediatrics Production and Share by Manufacturers (2012-2017)
    2.2 Global Anti-epileptic Drugs for Pediatrics Revenue and Share by Manufacturers (2012-2017)
    2.3 Global Anti-epileptic Drugs for Pediatrics Average Price by Manufacturers (2012-2017)
    2.4 Manufacturers Anti-epileptic Drugs for Pediatrics Manufacturing Base Distribution, Sales Area and Product Type
    2.5 Anti-epileptic Drugs for Pediatrics Market Competitive Situation and Trends
        2.5.1 Anti-epileptic Drugs for Pediatrics Market Concentration Rate
        2.5.2 Anti-epileptic Drugs for Pediatrics Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global Anti-epileptic Drugs for Pediatrics Capacity, Production, Revenue (Value) by Region (2012-2017)
    3.1 Global Anti-epileptic Drugs for Pediatrics Capacity and Market Share by Region (2012-2017)
    3.2 Global Anti-epileptic Drugs for Pediatrics Production and Market Share by Region (2012-2017)
    3.3 Global Anti-epileptic Drugs for Pediatrics Revenue (Value) and Market Share by Region (2012-2017)
    3.4 Global Anti-epileptic Drugs for Pediatrics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.5 North America Anti-epileptic Drugs for Pediatrics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.6 Europe Anti-epileptic Drugs for Pediatrics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.7 China Anti-epileptic Drugs for Pediatrics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.8 Japan Anti-epileptic Drugs for Pediatrics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.9 Southeast Asia Anti-epileptic Drugs for Pediatrics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.10 India Anti-epileptic Drugs for Pediatrics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Anti-epileptic Drugs for Pediatrics Supply (Production), Consumption, Export, Import by Region (2012-2017)
    4.1 Global Anti-epileptic Drugs for Pediatrics Consumption by Region (2012-2017)
    4.2 North America Anti-epileptic Drugs for Pediatrics Production, Consumption, Export, Import (2012-2017)
    4.3 Europe Anti-epileptic Drugs for Pediatrics Production, Consumption, Export, Import (2012-2017)
    4.4 China Anti-epileptic Drugs for Pediatrics Production, Consumption, Export, Import (2012-2017)
    4.5 Japan Anti-epileptic Drugs for Pediatrics Production, Consumption, Export, Import (2012-2017)
    4.6 Southeast Asia Anti-epileptic Drugs for Pediatrics Production, Consumption, Export, Import (2012-2017)
    4.7 India Anti-epileptic Drugs for Pediatrics Production, Consumption, Export, Import (2012-2017)

5 Global Anti-epileptic Drugs for Pediatrics Production, Revenue (Value), Price Trend by Type
    5.1 Global Anti-epileptic Drugs for Pediatrics Production and Market Share by Type (2012-2017)
    5.2 Global Anti-epileptic Drugs for Pediatrics Revenue and Market Share by Type (2012-2017)
    5.3 Global Anti-epileptic Drugs for Pediatrics Price by Type (2012-2017)
    5.4 Global Anti-epileptic Drugs for Pediatrics Production Growth by Type (2012-2017)

6 Global Anti-epileptic Drugs for Pediatrics Market Analysis by Application
    6.1 Global Anti-epileptic Drugs for Pediatrics Consumption and Market Share by Application (2012-2017)
    6.2 Global Anti-epileptic Drugs for Pediatrics Consumption Growth Rate by Application (2012-2017)
    6.3 Market Drivers and Opportunities
        6.3.1 Potential Applications
        6.3.2 Emerging Markets/Countries

7 Global Anti-epileptic Drugs for Pediatrics Manufacturers Profiles/Analysis
    7.1 Mylan N.V.
        7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.1.2 Anti-epileptic Drugs for Pediatrics Product Category, Application and Specification
            7.1.2.1 Product A
            7.1.2.2 Product B
        7.1.3 Mylan N.V. Anti-epileptic Drugs for Pediatrics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.1.4 Main Business/Business Overview
    7.2 Cephalon, Inc.
        7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.2.2 Anti-epileptic Drugs for Pediatrics Product Category, Application and Specification
            7.2.2.1 Product A
            7.2.2.2 Product B
        7.2.3 Cephalon, Inc. Anti-epileptic Drugs for Pediatrics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.2.4 Main Business/Business Overview
    7.3 GlaxoSmithKline plc
        7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.3.2 Anti-epileptic Drugs for Pediatrics Product Category, Application and Specification
            7.3.2.1 Product A
            7.3.2.2 Product B
        7.3.3 GlaxoSmithKline plc Anti-epileptic Drugs for Pediatrics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.3.4 Main Business/Business Overview
    7.4 Janssen Pharmaceuticals
        7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.4.2 Anti-epileptic Drugs for Pediatrics Product Category, Application and Specification
            7.4.2.1 Product A
            7.4.2.2 Product B
        7.4.3 Janssen Pharmaceuticals Anti-epileptic Drugs for Pediatrics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.4.4 Main Business/Business Overview
    7.5 Novartis AG
        7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.5.2 Anti-epileptic Drugs for Pediatrics Product Category, Application and Specification
            7.5.2.1 Product A
            7.5.2.2 Product B
        7.5.3 Novartis AG Anti-epileptic Drugs for Pediatrics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.5.4 Main Business/Business Overview
    7.6 Pfizer, Inc.
        7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.6.2 Anti-epileptic Drugs for Pediatrics Product Category, Application and Specification
            7.6.2.1 Product A
            7.6.2.2 Product B
        7.6.3 Pfizer, Inc. Anti-epileptic Drugs for Pediatrics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.6.4 Main Business/Business Overview
    7.7 Sanofi S.A.
        7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.7.2 Anti-epileptic Drugs for Pediatrics Product Category, Application and Specification
            7.7.2.1 Product A
            7.7.2.2 Product B
        7.7.3 Sanofi S.A. Anti-epileptic Drugs for Pediatrics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.7.4 Main Business/Business Overview
    7.8 UCB Pharma Limited
        7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.8.2 Anti-epileptic Drugs for Pediatrics Product Category, Application and Specification
            7.8.2.1 Product A
            7.8.2.2 Product B
        7.8.3 UCB Pharma Limited Anti-epileptic Drugs for Pediatrics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.8.4 Main Business/Business Overview
    7.9 Sunovion Pharmaceuticals Limited
        7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.9.2 Anti-epileptic Drugs for Pediatrics Product Category, Application and Specification
            7.9.2.1 Product A
            7.9.2.2 Product B
        7.9.3 Sunovion Pharmaceuticals Limited Anti-epileptic Drugs for Pediatrics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.9.4 Main Business/Business Overview
    7.10 Valeant Pharmaceuticals International, Inc.
        7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.10.2 Anti-epileptic Drugs for Pediatrics Product Category, Application and Specification
            7.10.2.1 Product A
            7.10.2.2 Product B
        7.10.3 Valeant Pharmaceuticals International, Inc. Anti-epileptic Drugs for Pediatrics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.10.4 Main Business/Business Overview
    7.11 Zogenix
    7.12 GW Pharmaceuticals
    7.13 Insys
    7.14 Zynerba

8 Anti-epileptic Drugs for Pediatrics Manufacturing Cost Analysis
    8.1 Anti-epileptic Drugs for Pediatrics Key Raw Materials Analysis
       8.1.1 Key Raw Materials
       8.1.2 Price Trend of Key Raw Materials
       8.1.3 Key Suppliers of Raw Materials
       8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
       8.2.1 Raw Materials
       8.2.2 Labor Cost
       8.2.3 Manufacturing Expenses
    8.3 Manufacturing Process Analysis of Anti-epileptic Drugs for Pediatrics

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 Anti-epileptic Drugs for Pediatrics Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of Anti-epileptic Drugs for Pediatrics Major Manufacturers in 2015
    9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List

11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
        11.1.1 Substitutes Threat
        11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

12 Global Anti-epileptic Drugs for Pediatrics Market Forecast (2017-2022)
    12.1 Global Anti-epileptic Drugs for Pediatrics Capacity, Production, Revenue Forecast (2017-2022)
        12.1.1 Global Anti-epileptic Drugs for Pediatrics Capacity, Production and Growth Rate Forecast (2017-2022)
        12.1.2 Global Anti-epileptic Drugs for Pediatrics Revenue and Growth Rate Forecast (2017-2022)
        12.1.3 Global Anti-epileptic Drugs for Pediatrics Price and Trend Forecast (2017-2022)
    12.2 Global Anti-epileptic Drugs for Pediatrics Production, Consumption , Import and Export Forecast by Region (2017-2022)
        12.2.1 North America Anti-epileptic Drugs for Pediatrics Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.2 Europe Anti-epileptic Drugs for Pediatrics Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.3 China Anti-epileptic Drugs for Pediatrics Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.4 Japan Anti-epileptic Drugs for Pediatrics Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.5 Southeast Asia Anti-epileptic Drugs for Pediatrics Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.6 India Anti-epileptic Drugs for Pediatrics Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
    12.3 Global Anti-epileptic Drugs for Pediatrics Production, Revenue and Price Forecast by Type (2017-2022)
    12.4 Global Anti-epileptic Drugs for Pediatrics Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology/Research Approach
        14.1.1 Research Programs/Design
        14.1.2 Market Size Estimation
        14.1.3 Market Breakdown and Data Triangulation
    14.2 Data Source
        14.2.1 Secondary Sources
        14.2.2 Primary Sources
    14.3 Disclaimer